Max Planck establishes a new research laboratory at Karolinska Institutet
[PRESS RELEASE 9 JUNE 2015] Karolinska Institutet and Max Planck Society, Germany, have signed an agreement on a new joint research laboratory at Karolinska Institutet specialising in congenital metabolic diseases.
The new Max Planck Institute for Biology of Ageing – Karolinska Institutet Laboratory is to be established in the Department of Laboratory medicine on Karolinska Institutet’s Solna campus, and will deepen existing research into congenital metabolic diseases.
“This initiative is part of Karolinska Institutet’s strategy to tie itself more closely to internationally leading research institutes,” says Karolinska Institutet vice-chancellor, Anders Hamsten.
At the Max Planck Institute in Cologne (the partner organisation) this research has, to date, mostly been done using animal models, and a new laboratory at Karolinska Institutet will offer fresh opportunities to collaborate using, amongst other resources, the unique patient material to which Karolinska Institutet’s leading scientists have access.
“Even if we’ll be collaborating on a small scale at first, it’s important to both parties,” says Hans-Gustaf Ljunggren, dean of research at Karolinska Institutet. “Together, we’ll advance our research in a way that would have been impossible had we been working alone.”
The collaborative programme is due to commence in 2015, and will run for five years under a common research group leader and with researchers recruited from Karolinska Institutet in Stockholm and visiting researchers from the Max Planck Institute in Cologne. There is also provision in the programme for doctoral students and postdocs to join as visiting researchers in both cities. Karolinska Institutet and the Max Planck Institute are investing the equivalent of 8.5 million kronor each in the programme.
For further information, contact:
Dean of Research Hans-Gustaf Ljunggren
Work: + 46 8-585 806 02
Email: hans-gustaf.ljunggren@ki.se
International coordinator Johanna Diehl
Work: + 46 8-524 863 84
Email: johanna.diehl@ki.se
Press Office
ki.se/pressroom
Karolinska Institutet is one of the world's leading medical universities. Its vision is to significantly contribute to the improvement of human health. Karolinska Institutet accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
Tags: